VIPRAGEN BIOSCIENCES PRIVATE LIMITED

Mysuru-based Vipragen Biosciences generated a revenue of Rs 2 crore during the FY19-20 exhibiting a decline in the business’ growth in comparison to Rs 3 crore generated during the previous financial year. Formed in 2012, Vipragen has in-depth research capabilities in Pre-clinical Biology, Microbiology, Molecular biology, Cell culture, Pharmacology, Toxicology, Drug Metabolism and Pharmacokinetics, drug discovery research, and new product development areas. The company brings forth scientific and research knowledge with deep expertise from a core team of scientists with a combined experience of over 120 years. Its team brings expertise from areas such as Molecular Biology, Cell Biology, Microbiology, Synthetic Chemistry, Medicinal and Veterinary Biology.